Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. MERCK RESEARCH LABORATORIES DIV MERCK CO INC
EIR
•MERCK RESEARCH LABORATORIES DIV MERCK CO INC•June 5, 2009

MERCK RESEARCH LABORATORIES DIV MERCK CO INC – FDA EIR, Jun 5, 2009

Record Details

An FDA inspection of Merck Research Laboratories in West Point, PA, was conducted from June 1-5, 2009. This comprehensive surveillance and full facility inspection of a nonclinical laboratory fell under the regulatory framework of C.P. 7348.808 (Nonclinical Laboratories), indicating adherence to Good Laboratory Practices (GLPs). The inspection resulted in a seven-item FDA Form 483, detailing significant observations. Key issues included a lack of documentation confirming proper handling of test article suspensions during dosing for three tracked studies. Final study reports were found deficient as they did not include signed and dated reports from individual contributing scientists. Furthermore, both study protocols and final reports failed to adequately identify all automated systems used for data collection, such as specific antemortem and pathology data systems. A crucial Standard Operating Procedure (SOP SA-4053) for bioanalytical method validation was noted to have excessively wide acceptance limits for stability assessments, potentially compromising data accuracy. The firm also did not maintain email correspondence specific to study activities, and pathology records indicated unexamined histopathological samples (tibia and lymph nodes) from certain animals in one study. Merck's management confirmed they would provide a written response to the Agency to address these inspectional observations.

Company
MERCK RESEARCH LABORATORIES DIV MERCK CO INC
Inspection date
June 5, 2009
Product type
Veterinary
Office
Office of Scientific Investigations
People
  • Zhou Chen (issuing_officer)
  • Mike M. Rashti (other)
  • Jacqueline A. O'Shaughnessy (Investigator at US FDA)
  • Abhijit Raha (other)
  • Michael J. Topper (company_representative)
View Company Profile

ID · 02be383f-bdfe-49c1-8e5f-58e812200df7

Violation Codes7
21 CFR 58.33(b)21 CFR 58.120(a)21 CFR 58.130(a)21 CFR 58.33(f)21 CFR 58.185(a)(6)21 CFR 58.185(a)(1)21 CFR 58.81(a)

Full citation text and observation details available on the Dashboard.

Other documents for MERCK RESEARCH LABORATORIES DIV MERCK CO INC
  • EIR - 2010-08-20August 20, 2010

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore MERCK RESEARCH LABORATORIES DIV MERCK CO INC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.